愛朋醫療(300753.SZ)完成變更醫療器械生產許可證
格隆匯 6 月 15日丨愛朋醫療(300753.SZ)公佈,公司於近日收到江蘇省藥品監督管理局換髮的《醫療器械生產許可證》,許可證編號:蘇食藥監械生產許20010280號,完成了生產地址的變更手續。
變更前生產地址:江蘇省如東縣經濟開發區永通大道東側;江蘇省南通市如東馬塘鎮建設路4號;變更後生產地址:江蘇省如東縣經濟開發區永通大道東側;江蘇省如東高新技術產業開發區悍業路西側。
為擴充產能,提高生產效率,公司建設實施愛朋醫療產業園項目,項目地址為江蘇省如東高新技術產業開發區悍業路西側。公司新廠區的投入使用,將滿足未來疼痛管理類產品和鼻腔護理類產品產能擴充的需求,同時提高相應產品生產的自動化程度,進一步提升產品質量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.